Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Brain Neoplasms 11Lung Neoplasms 3Glioblastoma 3Cognitive Dysfunction 3Breast Neoplasms 3Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Tobacco Use Disorder 1Recurrence 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neurotoxicity Syndromes 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Motor Activity 1Melanoma 1Gliosarcoma 1Gastrointestinal Neoplasms 1Fibrosis 1Epilepsy 1Ependymoma 1Craniopharyngioma 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Central Nervous System Carcinoma 1Carcinoma, Renal Cell 1

Interventions

Morphine 15Oxycodone 13Fentanyl 9nabiximols 5Methadone 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Hydromorphone 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Buprenorphine 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1naloxegol 1incobotulinumtoxinA 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cancer Pain × Memantine × Clear all
NCT04737967 2021-02-04

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Mendel AI

Phase 2/3 Unknown
60 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡